Scientific Programme
The Interplay of Immunology and Haematology
Uniting Hematologists, Oncologists, and Immunologists for Better Outcomes
The ESID-EHA-SIOPE 2025 meeting is more than just a conference—it’s a platform where the worlds of haematology, oncology, and immunology converge. As diseases like inborn errors of immunity (IEI), immune-mediated malignancies, and immune-related adverse effects cross traditional boundaries, collaboration among specialists becomes critical.

Why does this matter?
- Many conditions, such as immune-mediated cytopenias or lymphoma in IEI patients, require insights from all three fields.
- Advances in therapies like CAR T-cells or immune checkpoint inhibitors hinge on interdisciplinary understanding.
- Patients benefit from a holistic approach, where specialists collaborate to manage complex, multifaceted diseases.
Join us in shaping the future of integrative medicine as we explore cutting-edge science, translational research, and clinical practice.